The amyloidoses are a group of systemic diseases characterized by organ deposition of
misfolded protein fragments of diverse origins. The natural history of the disease …

Amyloid cardiomyopathy should be suspected in any patient who presents with heart failure
and preserved ejection fraction. In patients with echocardiographic evidence of ventricular …

Transthyretin amyloid cardiomyopathy (ATTR-CM) results in a restrictive cardiomyopathy
caused by extracellular deposition of transthyretin, normally involved in the transportation of …

Amyloidosis is a collection of systemic diseases characterised by misfolding of previously
soluble precursor proteins that become infiltrative depositions, thereby disrupting normal …

Cardiac amyloidosis, once considered a rare disease, has garnered significant attention
over the last few years due to three key reasons: first, increased recognition of this disease …

Cardiac amyloidosis (CA) is an infiltrative and restrictive cardiomyopathy that leads to heart
failure, reduced quality of life, and death. The disease has two main subtypes, transthyretin …

Cardiac amyloidosis or amyloid cardiomyopathy (ACM), commonly resulting from
extracellular deposition of amyloid fibrils consisted of misfolded immunoglobulin light chain …

Cardiac Amyloidosis is an infiltrative cardiomyopathy which occurs secondary to deposition
of mis-folded protein in the myocardium, with the two most common subtypes being AL …

Cardiac amyloidosis (CA), once thought to be a rare disease, is increasingly recognized due
to enhanced clinical awareness and better diagnostic imaging. CA is becoming of …

Cardiac amyloidosis in the United States is most often due to myocardial infiltration by
immunoglobulin protein, such as in AL amyloidosis, or by the protein transthyretin, such as …